Haorui Pharma-Chem Inc. (HPCI)
| About us | As a bulk pharmaceutical actives manufacturer, HPCI R&D labs and GMP factories are engaging in organic synthesis process development and manufacturing. HPCI is preparing APIs registration for USDMF (Drug Master File), EDMF, COS and TGA, and obtaining approval from regulatory agencies. As a bulk pharmaceuticals distributor HPCI represents some GMP bulk active pharmaceutical ingredient (API) manufacturers for international marketing and sales. Many of our bulk actives are produced by FDA inspected cGMP plants with drug master file (DMF) filed. Currently HPCI products are supplying to pharmaceutical companies in North America Europe, Australia and Latin America. |
|---|---|
| Industry Focus | Pharmaceutical Chemicals |
| Business Type | Manufacturer |
| Products/Services | Pharmaceutical chemicals |
| Our Markets | North America |
| No. of Employees | 51 - 100 People |
| Annual Sales Range(USD) | US$10 Million - US$50 Million |
| Year Established | 1989 |
| Legal Representative(CEO) | George Sun |
